BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//CITI Program - ECPv6.17.5//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:CITI Program
X-ORIGINAL-URL:https://about.citiprogram.org
X-WR-CALDESC:Events for CITI Program
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20261202T100000
DTEND;TZID=America/New_York:20261203T160000
DTSTAMP:20260930T141843Z
CREATED:20260930T141843Z
LAST-MODIFIED:20260930T141843Z
UID:63532-1796205600-1796313600@about.citiprogram.org
SUMMARY:Public Workshop: Evaluating Benefit-Risk in Robotic Medical Devices with Autonomous or Remote Teleoperation Capabilities
DESCRIPTION:The U.S. Food and Drug Administration (FDA) will host a hybrid\, two-day public workshop focused on autonomous and remote teleoperated robotic medical devices. The event will bring together a broad range of stakeholders\, including device manufacturers\, regulatory professionals\, healthcare providers\, patients\, and members of the public\, to discuss experiences with robotic technologies designed to interact with patients. The workshop aims to support dialogue on the benefits\, risks\, and real-world considerations associated with these evolving medical devices. \nWorkshop Objectives: \n\nFoster dialogue among stakeholders on terminology and key technical considerations for robotic medical devices with autonomous and/or remote teleoperation capabilities.\nBetter understand the probable benefits and risks of robotic medical devices with autonomous and/or remote teleoperation capabilities.\nExplore considerations for future policy development responsive to innovation while maintaining reasonable assurance of safety and effectiveness.\n\nThe workshop builds on the FDA’s longstanding engagement with the robotic medical device community and reflects ongoing efforts to better understand emerging technologies. The event will explore challenges and opportunities associated with advancing robotic medical devices while informing future regulatory and public health considerations. \nVisit the event page for more information.
URL:https://about.citiprogram.org/event/public-workshop-evaluating-benefit-risk-in-robotic-medical-devices-with-autonomous-or-remote-teleoperation-capabilities/
LOCATION:FDA White Oak Campus: The Great Room\, Building 31\, 10903 New Hampshire Avenue\, Silver Spring\, MD\, 20993\, United States
ATTACH;FMTTYPE=image/png:https://about.citiprogram.org/wp-content/uploads/2025/04/fda-logo.png
END:VEVENT
END:VCALENDAR